P3 Health Partners Inc. 8-K

What Happened P3 Health Partners Inc. (through its affiliate P3 Health Group, LLC) filed an 8‑K disclosing that on February 11, 2026 it entered into an Amendment to an Unsecured Promissory Note with VBC Growth SPV 5, LLC. The Amendment changes the Note dated May 29, 2025 to allow the remaining $19.0 million of the third tranche to be drawn in one or more advances through June 30, 2026. All other terms of the Note remain unchanged.

Key Details

• Parties: P3 Health Group, LLC and VBC Growth SPV 5, LLC.
• Original Note date: May 29, 2025; Amendment date: February 11, 2026; 8‑K filed February 17, 2026.
• Amount: $19.0 million remaining in the third tranche available for draws.
• Change: Extends availability period for that tranche through June 30, 2026; no other modifications disclosed.

Why It Matters This amendment preserves P3’s ability to access up to $19.0M of previously agreed funding through mid‑2026, which affects the company’s near‑term liquidity and financing flexibility. Because the instrument is an unsecured promissory note and other terms were not changed, investors should view this as an extension of funding timing rather than new capital or a change to repayment terms. Review the company’s upcoming filings for updates on whether and how much of the tranche is drawn and how it influences cash runway.